Contact this trialFirst, we need to learn more about you.
Chemotherapy
Vaccine + Chemotherapy for Head and Neck Cancer
Recruiting1 awardPhase 1 & 2
Chicago, Illinois
This trial is studying the safety and effectiveness of combining two experimental drugs, HB-201 and HB-202, with chemotherapy using carboplatin and paclitaxel. The study will also look at ways to reduce side effects overall using robotic surgery, chemotherapy and radiotherapy, or radiotherapy alone. Participation in the trial will last about 2 years.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.